Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Adalimumab/infliximab

Lupus: case report

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Adalimumab/infliximab. React. Wkly. 1277, 6 (2009). https://doi.org/10.2165/00128415-200912770-00018

    Download citation

    Keywords

    • Infliximab
    • Adalimumab
    • Mesalazine
    • Crohn Disease
    • Mercaptopurine